Nirav S. Jhaveri is CFO at Ocuphire Pharma, Inc. (OCUP). They have made 1 open-market trade across 1 company since 2024, most recently 2026-10-01.
CIK 0002011481
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $21K since 2024, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| OCUP | BUY | 2024-03-21 | 2024-03-25 | $2.10 | $21K | -5.4% | -24.3% | -20.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.